C07D 498/12
In which the condensed system contains three hetero rings
Official title: in which the condensed system contains three hetero rings
C07D498/12 (In which the condensed system contains three hetero rings) appears on 1,703 US grants and 2,129 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,703
- Published applications
- 2,129
- Assignees
- 836
- Inventors
- 5,730
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 6 | 0 |
| 1979 | 7 | 0 |
| 1980 | 10 | 0 |
| 1981 | 15 | 0 |
| 1982 | 13 | 0 |
| 1983 | 5 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 9 | 0 |
| 1988 | 12 | 0 |
| 1989 | 9 | 0 |
| 1990 | 11 | 0 |
| 1991 | 15 | 0 |
| 1992 | 29 | 0 |
| 1993 | 27 | 0 |
| 1994 | 21 | 0 |
| 1995 | 21 | 0 |
| 1996 | 38 | 0 |
| 1997 | 17 | 0 |
| 1998 | 13 | 0 |
| 1999 | 15 | 0 |
| 2000 | 12 | 0 |
| 2001 | 12 | 1 |
| 2002 | 19 | 26 |
| 2003 | 18 | 27 |
| 2004 | 11 | 31 |
| 2005 | 13 | 42 |
| 2006 | 15 | 47 |
| 2007 | 34 | 55 |
| 2008 | 27 | 43 |
| 2009 | 32 | 58 |
| 2010 | 34 | 70 |
| 2011 | 35 | 68 |
| 2012 | 48 | 84 |
| 2013 | 73 | 79 |
| 2014 | 77 | 114 |
| 2015 | 103 | 111 |
| 2016 | 88 | 108 |
| 2017 | 95 | 122 |
| 2018 | 81 | 94 |
| 2019 | 90 | 89 |
| 2020 | 77 | 109 |
| 2021 | 70 | 122 |
| 2022 | 81 | 118 |
| 2023 | 55 | 145 |
| 2024 | 78 | 143 |
| 2025 | 61 | 134 |
| 2026 | 63 | 89 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Substituted macrocyclic compounds and related methods of treatment6 Oct 2026US 12,753,188 B2Alkermes, Inc.
- Fibroblast activation protein ligands for targeted delivery applications29 Sep 2026US 12,747,224 B2Philochem AG
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- Macrocyclic glucagon-like peptide 1 receptor agonists15 Sep 2026US 12,735,433 B2Eli Lilly and Company
- Hexahydro[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine deuterated derivative, pharmaceutical composition thereof, preparation method therefor, and anti-influenza use thereof8 Oct 2026US 2026/0308174 A1Changsha Jingyi Pharmaceutical Technology Co., Ltd
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Heterocyclic compounds as parp1 inhibitors1 Oct 2026US 2026/0297102 A1Synnovation Therapeutics, Inc.
- Ras inhibitors1 Oct 2026US 2026/0297112 A1Revolution Medicines, Inc.
- Cyclic compounds used as multi-target kinase inhibitors and preparation method therefor24 Sep 2026US 2026/0285873 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
Most cited
By later US patents
- Fermentation process of preparing demethyl maytansinoids304US 4,361,650 ATakeda Chemical Industries, Ltd. · 1982
- Dechloromaytansinoids, their pharmaceutical compositions and method of use302US 4,256,746 ATakeda Chemical Industries, Ltd. · 1981
- Maytansinoids302US 4,322,348 ATakeda Chemical Industries, Ltd. · 1982
- Maytansinoids302US 4,331,598 ATakeda Chemical Industries, Ltd. · 1982
- Demethyl maytansinoids301US 4,307,016 ATakeda Chemical Industries, Ltd. · 1981